Virus-Based Nanoparticles for Tumor Selective Targeting and Oncolysis
Many oncolytic virotherapies have shown great advantages for rapid, rational design through recombinant DNA technology to facilitate the targeting of a broad spectrum of malignancies. Newcastle disease virus (NDV), an avian paramyxovirus, is naturally tumor-selective and inherently oncolytic. Our ap...
Main Author: | Chavan, Vrushali |
---|---|
Other Authors: | Veterinary Medical Sciences |
Format: | Others |
Language: | en_US |
Published: |
Virginia Tech
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/10919/76938 http://scholar.lib.vt.edu/theses/available/etd-12232010-124413/ |
Similar Items
-
In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells
by: Ahmed M. Al-Shammari, et al.
Published: (2016-01-01) -
Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
by: Noemi García-Romero, et al.
Published: (2020-06-01) -
Intratumoral Virotherapy with Wild-Type Newcastle Disease Virus in Carcinoma Krebs-2 Cancer Model
by: Kseniya S. Yurchenko, et al.
Published: (2021-03-01) -
Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma
by: Pascal Buijs, et al.
Published: (2015-06-01) -
Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series
by: Benjamin Gesundheit, et al.
Published: (2020-05-01)